Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Obesity × Exergaming × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Neoplasms 2 Stroke 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 1 Obesity 1 Multiple Sclerosis 1 Motor Activity 1 Leukemia 1 Fatigue 1 Diabetes Mellitus 1 Cognitive Dysfunction 1 Breast Neoplasms 1 Brain Injuries 1 Arthritis 1

Interventions

Exercise 22 Metformin 14 Tirzepatide 8 Diet 8 Resistance Training 7 Nutrition Assessment 7 Methods 7 Diet Therapy 7 Counseling 6 semaglutide 5 Exenatide 5 Early Intervention, Educational 5 Diet, Mediterranean 5 Caloric Restriction 5 Blood Specimen Collection 5 Surveys and Questionnaires 4 Liraglutide 4 Educational Status 4 Bariatric Surgery 4 Vitamin D 3 Standard of Care 3 Naltrexone 3 Letrozole 3 Docosahexaenoic Acids 3 Dexamethasone 3 Bupropion 3 exemestane 2 bupropion hydrochloride, naltrexone hydrochoride drug combination 2 Yoga 2 Topiramate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02152462 2020-02-10

POWER

Georgetown University

Phase 2 Completed

Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡